Please provide your email address to receive an email when new articles are posted on . Immediate sequential bilateral cataract surgery with implantation of multifocal IOLs showed comparable outcomes ...
Patients now have several exciting—although not yet perfect—multifocal intraocular lenses (IOLs) for presbyopia correction from which to choose. Currently in the United States, the recently approved ...
Please provide your email address to receive an email when new articles are posted on . AMELIA ISLAND, Fla. — Patients with multifocal IOLs are more likely to develop vitreous opacities and have a ...
Same-day bilateral cataract surgery led to vision outcomes that were at least as good as those with delayed sequential procedures, with limited impact on most patients' daily activities, according to ...
Patients who have a new type of lens implanted in their eyes during surgery for cataracts or to correct their eyesight have excellent or good vision over distances both near and far, and often no ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--The company Swiss Advanced Vision (SAV-IOL SA) announced today the launch of LUCIDIS and EDEN, two new intraocular lenses (IOLs) for the cataract surgery, both ...
The MICS IOLs can be safely implanted through incision less than 1.8 mm. The only limitations for MICS procedure is the small amount of the MICS lenses. Up to now there are only few lenses performing ...
FORT WORTH, Texas--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof ® IQ Vivity ® and Clareon ® Vivity ...
The Healthy @Reader's Digest on MSN
What I wish I’d known about cataract surgery: A doctor details what patients should know ...
An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of miracle and wonder." Cataracts are a common eye condition that affects ...
Among many presentations during a hot topics session at the American Academy of Ophthalmology 2021 annual meeting, speakers discussed the first FDA approved therapy for thyroid eye disease and the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果